1. Home
  2. SLN vs VPG Comparison

SLN vs VPG Comparison

Compare SLN & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • VPG
  • Stock Information
  • Founded
  • SLN 1994
  • VPG 2009
  • Country
  • SLN United Kingdom
  • VPG United States
  • Employees
  • SLN N/A
  • VPG N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • VPG Electrical Products
  • Sector
  • SLN Health Care
  • VPG Technology
  • Exchange
  • SLN Nasdaq
  • VPG Nasdaq
  • Market Cap
  • SLN 352.2M
  • VPG 283.7M
  • IPO Year
  • SLN N/A
  • VPG N/A
  • Fundamental
  • Price
  • SLN $6.47
  • VPG $24.34
  • Analyst Decision
  • SLN Strong Buy
  • VPG Hold
  • Analyst Count
  • SLN 4
  • VPG 1
  • Target Price
  • SLN $61.50
  • VPG $31.00
  • AVG Volume (30 Days)
  • SLN 959.2K
  • VPG 134.4K
  • Earning Date
  • SLN 11-14-2024
  • VPG 11-05-2024
  • Dividend Yield
  • SLN N/A
  • VPG N/A
  • EPS Growth
  • SLN N/A
  • VPG N/A
  • EPS
  • SLN N/A
  • VPG 0.99
  • Revenue
  • SLN $21,773,221.00
  • VPG $323,397,000.00
  • Revenue This Year
  • SLN N/A
  • VPG N/A
  • Revenue Next Year
  • SLN $104.98
  • VPG $1.31
  • P/E Ratio
  • SLN N/A
  • VPG $24.45
  • Revenue Growth
  • SLN N/A
  • VPG N/A
  • 52 Week Low
  • SLN $5.81
  • VPG $20.83
  • 52 Week High
  • SLN $27.72
  • VPG $35.98
  • Technical
  • Relative Strength Index (RSI)
  • SLN 27.24
  • VPG 56.18
  • Support Level
  • SLN $6.06
  • VPG $23.68
  • Resistance Level
  • SLN $8.88
  • VPG $25.44
  • Average True Range (ATR)
  • SLN 0.72
  • VPG 0.87
  • MACD
  • SLN 0.22
  • VPG 0.09
  • Stochastic Oscillator
  • SLN 22.52
  • VPG 57.55

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates majority of its revenue from United States.

Share on Social Networks: